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There is evidence worldwide of a temporal decline in 
mother-to-child transmission rates for HIV-l infection.‘-’ 
Although this is generally attributed to increased use of 
zidovudine in industrialized countries,’ timing of the 
decline in such countries and observations in the devel- 
oping world both raise the possibility of a general decline 
in the absence of antiretroviral therapy.2,3 Cost-effective- 
ness of interventions could vary dramatically over time 
and must be considered by policy makers, particularly in 
the developing world. 
Recommended modifications in obstetric practice 
may have played a role in declining rates of vertical trans- 
mission4 However, there are two reasons, linked to stage 
of the human immunodeficiency virus-acquired immuno- 
deficiency syndrome (HIV-AIDS) epidemic, why a dra- 
matic fall in mother-to-child transmission rate is to be 
expected in the absence of specific interventions, at least 
in Africa. Early in an epidemic, most HIV-positive women 
are recently infected, and many experience primary HIV 
infection during pregnancy.5,” Delay in achieving viral 
“set point” could result in high risk of transmission in 
utero, intrapartum, and during breastfeeding. Cytotoxic 
CDS cells remain high for up to 6 months after infec- 
tion,’ and high CDS levels in pregnancy have been asso- 
ciated with mother-to-child transmission.* Rates of 
transmission of 50% have been observed in such 
patients.’ It is striking that African reports of high 
mother-to-child transmission are from early in the epi- 
demic in the study location (Table 1).“-18 
An epidemic of AIDS may be attributable to waves 
of seroconversions sweeping through sexual net- 
works.‘” The ultimate size of an epidemic may vary, as 
shown in Table 1, but dependence on high transmission 
during primary HIV-l infection remains. Therefore, it 
is not surprising that mother-to-child transmission rates 
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are similar in West, East, and South Africa provided stud- 
ies are compared according to stage of the epidemic. 
Each of the studies recruited at a time when HIV-l 
prevalence was rising or had stabilized in that partic- 
ular year. It seems clear that, even in the absence of 
specific behavioral interventions, high-risk behavior 
declines when AIDS mortality rises.19 In Africa, AIDS 
cases peak 3 to 5 years after seroprevalence stabilizes.‘” 
Thus, the proportion of women with multiple partners, 
a risk factor for mother-to-child transmission2” and 
unprotected sex generally are both likely to decline 
once prevalence peaks. 
It has been suggested that multiple episodes of 
unprotected sex could further increase the risk of peri- 
natal HIV-l transmission beyond the known risk of sex- 
ual behavior in transmission during primary HIV-l 
infection.22x23 In a retrospective study from New York, 
mother-to-child transmission varied from 9% in women 
denying unprotected sex to 39% in those women report- 
ing inconsistent condom use and 80 or more episodes of 
intercourse during pregnancy2* In a prospective study, 
also from New York, risk of perinatal transmission was 
again associated with frequency of unprotected inter- 
course.Z3 It is reasonable not just to promote behavior 
change, but to assume that such change alters transmis- 
sion rates. 
Although changes in definitions and tests used may 
have played a role, regional variations and time trends in 
mother-to-child transmission could be attributable, in part, 
to the factors described above.24 These issues should be 
discussed in any meta-analysis, and observational studies 
recruiting patients over prolonged periods should regard 
time as a potential confounder. The effect of time period 
should be examined for each component of mother-to- 
child transmission, because differences in obstetric prac- 
tice will chiefly affect the perinatal component, whereas 
primary HIV-l infection may dramatically alter risk of 
transmission during breastfeeding. Furthermore, owing 
to persisting high HIV-l incidence in young women, 
trends may vary by age.“,‘” Most importantly, the cost- 
effectiveness of interventions may decline as underlying 
transmission rates fall. 
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Table 1. Relation of Mother-to-Child Transmission Rate to Stage of HIV-1 Epidemic 
Fansmission HIV Recruitment Year of Peak 
Study Location Rate (%) Prevalence (%) Period Prevalence 
Kinshasa Zaireg,lo 
Lusaka, ?ambiall,lz 
39* 6 1986-l 987 1986 
39 12 1987 1990 
Brazaville, Congo13’14 40 - 1987 1994 
Blantyre, Malawi15,16 35 23 1990 1993 
Durban, South Africai7,18 34+ 10 1990-l 993 1998 
*Based on a randomly selected sample; +39% in breastfed infants. 
Peak H/V 
Prevalence (%) 
6 
25 
7 
30 
33 
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